Pathogenesis, diagnostics, and therapeutics for Alzheimer's disease: Breaking the memory barrier.
Level 5 - mechanism / opinion, no new human data
Narrative review without systematic search methodology or primary empirical data.
PubMed 39236855 · doi:10.1016/j.arr.2024.102481
What was done
This paper is a narrative review synthesizing literature on Alzheimer's disease mechanisms, current diagnostic approaches, and emerging therapeutic interventions.
What was found
The abstract reports that Alzheimer's disease accounts for 60% to 70% of dementia cases globally and describes general clinical features including cognitive decline and memory loss. No specific empirical findings, effect sizes, or quantitative trial outcomes are reported in the abstract.
Why it matters
It provides a broad, high-level synthesis of existing concepts across pathogenesis, diagnostics, and pipeline therapies for Alzheimer's disease.
Limits
The abstract does not describe a systematic search strategy, quality appraisal of included literature, or quantitative synthesis. No original patient data or statistical comparisons are provided.
Cited by
- supports Alzheimer's disease accounts for 70% of dementia cases.